3 hours UBS Group Initiates Coverage on Immunocore (NASDAQ:IMCR)MarketBeat
UBS Group began coverage on shares of Immunocore in a research note on Thursday. They set a “sell” rating and a $24.00 price objective on the stock.
XUBS Group began coverage on shares of Immunocore in a research note on Thursday. They set a “sell” rating and a $24.00 price objective on the stock.
X